Pyridoxine-dependent and other pyridoxine-responsive epilepsies—insights into phenotype overlapping and the long-term outcome in a cohort of 21 children - Takeaways - MDSpire

Pyridoxine-dependent and other pyridoxine-responsive epilepsies—insights into phenotype overlapping and the long-term outcome in a cohort of 21 children

  • By

  • Ružica Kravljanac

  • Biljana Vučetić Tadić

  • Vladimir Oparnica

  • July 13, 2026

Share

  • 1

    The study evaluated 21 children with pyridoxine-responsive seizures, focusing on etiology, phenotype, and long-term outcomes.

  • 2

    Patients were divided into two groups: pyridoxine-dependent epilepsy (PDE) and pyridoxine-responsive epilepsy (PRE) with various etiologies.

  • 3

    The median age at seizure onset was 2 days for both groups, with no significant difference in the time to pyridoxine treatment.

  • 4

    Seizure freedom was achieved in 80% of PDE patients and 72.7% of PRE patients, while developmental delays were noted in over half of both groups.

  • 5

    MRI abnormalities were observed in 80% of PDE and 63.6% of PRE patients, indicating significant differences in neuroimaging findings.

Original Source(s)

Pyridoxine-dependent and other pyridoxine-responsive epilepsies—insights into phenotype overlapping and the long-term outcome in a cohort of 21 children

  • by Ružica Kravljanac, Biljana Vučetić Tadić, Vladimir Oparnica

  • July 13, 2026

Related Content

PTSD May Be Linked to Accelerated Aging

Integrated proteomic and metabolomic analyses identified redox-metabolic signatures associated with chronic posttraumatic stress disorder and accelerated biological aging across multiple organ systems.

Early arterial blood gas parameters, clinical features, and neuroimaging findings in neonates undergoing therapeutic hypothermia for suspected hypoxic-ischemic encephalopathy: a retrospective single-center study

Editorial: Cross-talk of synaptic proteins in neurological diseases